| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/20/2005 | WO2005004794A2 Method of treating neurodegenerative disease |
| 01/20/2005 | WO2005004793A2 Compositions and methods for treating coagulation related disorders |
| 01/20/2005 | WO2005004792A2 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 01/20/2005 | WO2005004791A2 Compounds and methods for the treatment and prevention of bacterial infection |
| 01/20/2005 | WO2005004790A2 Liquid massage composition for the cure of acute chronic vertebral hernia, diseases of joint, arthritis, calcification and for the regulation of blood circulation |
| 01/20/2005 | WO2005004789A2 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 01/20/2005 | WO2004105780A3 Compositions comprising gastrin compounds and their use in diabetes |
| 01/20/2005 | WO2004103265A3 Whitening and antioxidative cosmetic composition containing resveratrol and method for preparing the same |
| 01/20/2005 | WO2004100865A3 New benzimidazole derivatives |
| 01/20/2005 | WO2004098510A3 Cystic fibrosis therapy |
| 01/20/2005 | WO2004098507A3 1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof |
| 01/20/2005 | WO2004096129A3 Inhibitors of akt activity |
| 01/20/2005 | WO2004096126A3 Treating hepatocellular carcinomas using therapeutic viruses |
| 01/20/2005 | WO2004093788A9 Desmoglein 4 is a novel gene involved in hair growth |
| 01/20/2005 | WO2004091486A3 Compounds for the treatment of metabolic disorders |
| 01/20/2005 | WO2004084833A3 Jucara and açai fruit-based dietary supplements |
| 01/20/2005 | WO2004082608A3 Ligands for tgf-beta binding proteins and uses thereof |
| 01/20/2005 | WO2004080390A3 Antiprotozoal imidazopyridine compounds |
| 01/20/2005 | WO2004078131A3 Evaluating effects of exposure conditions on drug samples over time |
| 01/20/2005 | WO2004075862A3 Crosslinkable polymeric materials and their applications |
| 01/20/2005 | WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/20/2005 | WO2004073622A3 Novel therapeutic method and compositions for topical administration |
| 01/20/2005 | WO2004071398A3 Pharmaceutical patch |
| 01/20/2005 | WO2004069158A3 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 01/20/2005 | WO2004066940A3 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 01/20/2005 | WO2004064761A3 Therapeutically active compounds |
| 01/20/2005 | WO2004064742A9 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 01/20/2005 | WO2004034995A3 Methods and reagents for inducing immunity |
| 01/20/2005 | US20050015760 Automatic detection and patching of vulnerable files |
| 01/20/2005 | US20050015263 Therapy for central nervous system disorders; amyotropic lateral sclerosis; anticancer agents; eating disorders; viricides |
| 01/20/2005 | US20050014962 Novel lipids for transfection of nucleic acids |
| 01/20/2005 | US20050014955 Process for the preapartion 3-aryl-2-hydroxypropionic acid derivative |
| 01/20/2005 | US20050014839 Histone deacetylase inhibitors and methods of use thereof |
| 01/20/2005 | US20050014838 Triggering microvessel dilation in striated muscle utilizing either cannabinoid receptor 1 agonist or cyclooxygenase activator and increasing uptake with beta 3 adrenergic receptor agonist |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/20/2005 | US20050014774 Oxo-pyrimidine compounds |
| 01/20/2005 | US20050014767 Controlling cell proliferative |
| 01/20/2005 | US20050014766 Use of n-(indolecarbonyl-)piperazine derivatives |
| 01/20/2005 | US20050014755 Tetracyclic compounds as c-Met inhibitors |
| 01/20/2005 | US20050014754 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 01/20/2005 | US20050014753 Antitumor agents |
| 01/20/2005 | US20050014752 Viricides; anticancer bagents; nucleotides, nucleosides |
| 01/20/2005 | US20050014743 Synergistic mixture; antidepressants; multiple sclerosis; Parkinson's disease; Alzheimer's disease; antitumor agents; sleep disorders; glandular disorders |
| 01/20/2005 | US20050014737 Antiangiogenic agents |
| 01/20/2005 | US20050014732 Combination of an aldosterone receptor antagonist and an anti-diabetic agent |
| 01/20/2005 | US20050014728 Therapy or prevention of diseases caused by lymphocyte interaction; antiinflamamtory agents; autoimmune disease |
| 01/20/2005 | US20050014727 Antiinflammatoy agents; antiallergens; antiproliferative agents; skin disorders; viral disorders; Alzheimer's disease; muscular disorders; antiarthritic agents |
| 01/20/2005 | US20050014724 Immunosuppressant compounds and compositions |
| 01/20/2005 | US20050014716 Pancreatic cancer treatment |
| 01/20/2005 | US20050014714 Gene delivery to organs |
| 01/20/2005 | US20050014697 Reduce concentration of nitric oxide ; antiinflamamtory agents, stroke, antiproliferative agents; gastrointestinal disorders; inflammatory bowel disorders; antiarthritic agents; Parkinson's disease; Alzheimer's disease;amyotroic lateral sclerosis; anticancer agents |
| 01/20/2005 | US20050014692 Isolate nucleic acids; intensify stimulated insulin elimination; antidiabetic agents |
| 01/20/2005 | US20050013836 Antimicrobial flush solutions |
| 01/20/2005 | US20050013826 Administering modified protein having disruptive element located in internal region; enhancing ubiquitin proteasome system degradation; effective, long term T cell response |
| 01/20/2005 | US20050013821 Mint extract and related pharmaceutical compositions |
| 01/20/2005 | US20050013781 photoprotective composition requiring little optimization agent to efficiently optimize polarity, critical wavelength, photostability, Sun protection factor (SPF), Protection Factor for UVA (PFA) and Star Rating |
| 01/20/2005 | CA2531118A1 Multivalent carriers of bi-specific antibodies |
| 01/20/2005 | CA2530980A1 Tissue factor-specific antibodies for preventing or treating acute lung injury or acute respiratory distress syndrome |
| 01/20/2005 | CA2530534A1 Gelled starch compositions and methods of making gelled starch compositions |
| 01/20/2005 | CA2530529A1 Compositions and methods for selective dissolution of nascent intravascular blood clots |
| 01/20/2005 | CA2530006A1 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529994A1 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | CA2529323A1 Tetracyclic compounds as c-met inhibitors |
| 01/20/2005 | CA2528587A1 .beta.-lactamase inhibitors and methods of use thereof |
| 01/20/2005 | CA2528120A1 Methods for treating lentivirus infections |
| 01/19/2005 | EP1497322A2 Treatment of infections and other disorders |
| 01/19/2005 | EP1497266A2 Quinoline derivatives and their use as 5-ht6 ligands |
| 01/19/2005 | EP1496891A2 Methods for modulating phototoxicity |
| 01/19/2005 | EP1496810A2 Method and apparatus for controlling sub-clinical laser procedures with intra-operative monitoring of electrophysiological changes |
| 01/19/2005 | EP1418929A4 Simmondsin processing methods and products |
| 01/19/2005 | EP1272199B1 Combination therapies with vascular damaging activity |
| 01/19/2005 | EP0994880B1 Crystalline macrolides and process for their preparation |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568183A Citalopram for the treatment of elevated blood pressure |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |
| 01/18/2005 | US6843993 Anti-microbial-adhesion fraction derived from vaccinium |
| 01/16/2005 | CA2471998A1 Automatic detection and patching of vulnerable files |
| 01/13/2005 | WO2005002529A2 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 01/13/2005 | WO2005002528A2 Method for treating diabetes |
| 01/13/2005 | WO2005002527A2 Sirt1 modulation of adipogenesis and adipose function |
| 01/13/2005 | WO2005002526A2 Method and compositions for treatment of viral infections |
| 01/13/2005 | WO2005002525A2 Cox-2 and faah inhibitors |
| 01/13/2005 | WO2005002524A2 COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES OF OLEOYLETHANOLAMIDE-LIKE COMPOUNDS AND MODULATORS OF PPARα |
| 01/13/2005 | WO2005002523A2 Process for preparing highly pure and free-flowing solid of 7-ethyltryptophol |
| 01/13/2005 | WO2005002522A2 Compositions and methods for treating tissue ischemia |
| 01/13/2005 | WO2005002521A2 Methods for the identification of inhibitors of acetolactate synthase and potassium transport protein as antibiotics |
| 01/13/2005 | WO2005002520A2 Ophthalmic compositions for treating ocular hypertension |
| 01/13/2005 | WO2005002519A2 Amphiphilic pyridinium compounds, method of making and use thereof |
| 01/13/2005 | WO2005002518A2 Methods for treating and preventing cardiac arrhythmia |
| 01/13/2005 | WO2005002516A2 Leukocyte internalized peptide-drug conjugates |
| 01/13/2005 | WO2005002515A2 Delivery of therapeutic compounds to the brain and other tissues |
| 01/13/2005 | WO2005002514A2 Compounds having inhibitibe activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 01/13/2005 | WO2005002513A2 C1q complement inhibitors and methods of use thereof |
| 01/13/2005 | WO2005002512A2 Immunotherapeutic vaccine strategy |
| 01/13/2005 | WO2005002510A2 Deployable multifunctional hemostatic agent |
| 01/13/2005 | WO2005002509A2 Dna vectors |